Trials / Completed
CompletedNCT01991444
CGA-TAVI Registry to Evaluate the Predictive Value of a CGA in Predicting TAVI Outcomes
Registry Study to Evaluate the Predictive Value of a Comprehensive Geriatric Assessment With Regard to the Outcome of a Transcatheter Aortic Valve Implantation.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 72 (actual)
- Sponsor
- Institut für Pharmakologie und Präventive Medizin · Network
- Sex
- All
- Age
- 80 Years
- Healthy volunteers
- Not accepted
Summary
Registry study to evaluate the predictive value of a comprehensive geriatric assessment with regard to the outcome of a transcatheter aortic valve Implantation. It will be evaluated which parts of the comprehensive geriatric assessment (CGA) are best suited to predict the therapeutic success of a heart valve Implantation in elderly ( \> 80 years) Patient. Possible participants are all Patient of 80 years or above for whom the implantation of a Edwards Sapien XT aortic valve is planned
Detailed description
Transcatheter Aortic Valve Implantation Registry with Comprehensive Geriatric Assessment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | TAVI | no Intervention planned, Observation only |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2016-12-01
- Completion
- 2017-02-01
- First posted
- 2013-11-25
- Last updated
- 2017-04-05
Locations
3 sites across 3 countries: Canada, Italy, Netherlands
Source: ClinicalTrials.gov record NCT01991444. Inclusion in this directory is not an endorsement.